SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-09-069866
Filing Date
2009-12-10
Accepted
2009-12-10 16:15:02
Documents
3
Period of Report
2009-12-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K g21524e8vk.htm 8-K 13886
2 EX-99.1 g21524exv99w1.htm EX-99.1 8577
3 GRAPHIC g21524g2152400.gif GRAPHIC 2512
  Complete submission text file 0000950123-09-069866.txt   27705
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23186 | Film No.: 091233944
SIC: 2836 Biological Products, (No Diagnostic Substances)